Skin autofluorescence is not a good marker for disease status in COPD

P. Gopal, E. Rutten, N. Reynaert, N. Ten Hacken, E. Wouters (Maastricht, Horn, Groningen, Netherlands)

Source: Annual Congress 2011 - COPD diagnosis
Session: COPD diagnosis
Session type: Thematic Poster Session
Number: 3573
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Gopal, E. Rutten, N. Reynaert, N. Ten Hacken, E. Wouters (Maastricht, Horn, Groningen, Netherlands). Skin autofluorescence is not a good marker for disease status in COPD. Eur Respir J 2011; 38: Suppl. 55, 3573

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Markers of early disease and prognosis in COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009


Ultrasound diaphragm activity as a marker of clinical status and prognosis in acute exacerbations of COPD
Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD
Year: 2021



Lung function reversibility as a predictor of disease progression in COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Red cell distribution width (RDW) as a biomarker of disease severity in ILD patients
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015

The relationship between bronchial inflammation and markers of disease progression in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 179s
Year: 2003

Functional status in patients with chronic lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 652s
Year: 2007

Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001

Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients?
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015

Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008

Chronic obstructive lung disease and vitamin D status: Relationship with lung function, inflammatory status and exacerbations
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


Functional status in high and low risk patient with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD
Year: 2013


Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020


Systemic inflammation and nutritive status in patients with COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020

Predicting progression of RA-ILD using anti-CCP
Source: International Congress 2015 – Connective tissue disorders
Year: 2015


Discrepancy of non-invasive inflammatory markers and lung function tests to current level of clinical control in childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Biological and phenomenological markers of ageing in patients with COPD and their relationship to CT emphysema scores
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015